United States Pharmacopeia (usp.org) is an independent scientific organization that collaborates with the world’s top experts in health and science to develop quality standards for medicines, dietary supplements, and food ingredients. Through its resources, standards, advocacy, and education, USP helps ensure the availability of quality medicines, supplements, and foods for billions of people worldwide.

The acquisition of Stratix Labs marks a significant milestone for USP’s portfolio, as it will expand its microbiological solutions supporting microbial contamination control with broad applications across pharmaceuticals, including biologics and compounded medications. Microbiological quality controls are essential to ensure fundamental contamination control measures are in place during pharmaceutical production and preparation. Increased demand and expedited timelines require the industry to identify and implement new approaches to quality control throughout the drug production process, particularly for sterile products. By acquiring Stratix Labs, USP will be better equipped to help drug manufacturers, developers, and compounding entities address industry gaps in microbial contamination control strategies, mitigating the risk of contaminated products reaching patients.

Headquartered in Saint Paul, MN, Stratix Labs (stratixlabs.com) develops and produces tools that simplify workflows and improve the robustness of microbiological quality controls. Stratix Labs is a supplier of materials that can be further developed into reference materials and standards. Stratix Lab’s innovative microbial preservation technology, which powers its products, will have broad applications across industries relevant to USP, such as pharmaceutical and biopharmaceutical manufacturing, compounded medicines, and foods.

Delancey Street Partners is an independent, industry-focused investment bank. We serve CEOs, Entrepreneurs, Shareholders, and Boards of Directors of high growth and middle market private and public companies. Our services include strategic advisory, capital raising, and independent board advice. We advise on sell-side and buy-side M&A, growth capital financings, and recapitalizations. Our focus sectors include Healthcare, Industrial & Industrial Technology, Business Services & Technology, and Infrastructure. We form long-term partnerships with our clients and commit to managing each engagement with senior professionals who bring years of experience and insight.